Ligand validation:4IOK

TOE: 2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL

TOE is a Ligand Of Interest in 4IOK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IOK_TOE_A_605	62%	73%	0.137	0.93	0.62	0.43	-	-	0	0	100%	1
4IOK_TOE_B_605	45%	68%	0.176	0.906	0.71	0.52	-	-	0	0	100%	1
4IOK_TOE_A_606	26%	63%	0.176	0.815	0.83	0.61	-	-	1	0	100%	1
4JJZ_TOE_B_604	68%	59%	0.139	0.952	0.77	0.8	-	-	1	0	100%	1
4IOJ_TOE_B_603	67%	68%	0.11	0.919	0.65	0.58	-	-	0	0	100%	1
4JIM_TOE_B_601	58%	69%	0.151	0.929	0.67	0.53	-	-	1	0	100%	1
4JJK_TOE_B_601	48%	74%	0.173	0.917	0.63	0.4	-	-	0	0	100%	1
4IOM_TOE_B_600	44%	77%	0.184	0.911	0.55	0.37	-	-	0	0	100%	1
5JEI_TOE_A_306	59%	70%	0.104	0.883	0.77	0.39	-	-	1	0	100%	1
7NJC_TOE_A_600	54%	86%	0.113	0.876	0.5	0.22	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.